Polypharmacy to Optimize Depression Outcomes

摘要

Polypharmacy is used increasingly in the treatment of depression.1 Although it can be beneficial—and at times may even be unavoidable—it can also be overused, resulting in drug-drug interactions, accumulation of adverse effects, reduced treatment adherence, and unnecessary increases in the cost of health care.2 This article describes current trends in psychiatric polypharmacy in the treatment of depression along with ways to use polypharmacy to optimize treatment outcomes.